FOLD Historical PE Ratio image   This FOLD PE ratio history page last updated 11/8/2024
FOLD Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q3 2024
11/6/2024
11.240.100.4028.1
Q2 2024
8/8/2024
11.320.060.2447.2
Q1 2024
5/9/2024
9.48-0.02-0.08NA
Q4 2023
2/28/2024
12.950.010.04323.8
Q3 2023
11/8/2023
11.36-0.07-0.28NA
Q2 2023
8/8/2023
13.86-0.15-0.60NA
Q1 2023
5/10/2023
11.58-0.18-0.72NA
Q4 2022
3/1/2023
13.54-0.19-0.76NA
Q3 2022
11/7/2022
10.31-0.12-0.48NA
Q2 2022
8/4/2022
10.94-0.21-0.84NA
Q1 2022
5/9/2022
6.23-0.30-1.20NA
Q4 2021
2/24/2022
8.48-0.29-1.16NA
Q3 2021
11/9/2021
11.32-0.19-0.76NA
Q2 2021
8/5/2021
10.06-0.19-0.76NA
Q1 2021
5/10/2021
9.39-0.25-1.00NA
Q4 2020
3/1/2021
11.79-0.27-1.08NA
Q3 2020
11/5/2020
21.34-0.22-0.88NA
Q2 2020
8/10/2020
15.23-0.20-0.80NA
Q1 2020
5/7/2020
11.62-0.35-1.40NA
Q4 2019
3/2/2020
9.32-0.35-1.40NA
Q3 2019
11/11/2019
9.28-0.24-0.96NA
Q2 2019
8/8/2019
11.39-0.36-1.44NA
Q1 2019
5/8/2019
13.11-0.39-1.56NA
Q4 2018
2/28/2019
12.10-0.41-1.64NA
Q3 2018
11/5/2018
11.71-0.31-1.24NA
Q2 2018
8/7/2018
15.63-0.33-1.32NA
Q1 2018
5/8/2018
13.58-0.28-1.12NA
Q4 2017
2/28/2018
13.76-0.41-1.64NA
Q3 2017
11/8/2017
13.17-0.41-1.64NA
Q2 2017
8/7/2017
13.90-0.34-1.36NA
Q1 2017
5/9/2017
6.65-0.39-1.56NA
Q4 2016
3/1/2017
7.60-0.42-1.68NA
Q3 2016
11/7/2016
7.43-0.33-1.32NA
Q2 2016
8/9/2016
6.34-0.40-1.60NA
Q1 2016
5/3/2016
7.07-0.35-1.40NA
Q4 2015
2/26/2016
6.23-0.35-1.40NA
Q3 2015
11/3/2015
8.83-0.32-1.28NA
Q2 2015
8/5/2015
18.19-0.27-1.08NA
Q1 2015
5/5/2015
10.28-0.25-1.00NA
Q4 2014
3/3/2015
8.48-0.24-0.96NA
Q3 2014
11/6/2014
5.88-0.22-0.88NA
Q2 2014
8/7/2014
4.02-0.22-0.88NA
Q1 2014
5/5/2014
2.15-0.25-1.00NA
Q4 2013
3/3/2014
2.57-0.22-0.88NA
Q3 2013
11/12/2013
2.04-0.29-1.16NA
Q2 2013
8/7/2013
2.62-0.31-1.24NA
Q1 2013
5/9/2013
3.11-0.35-1.40NA
Q4 2012
3/12/2013
3.10-0.20-0.80NA
FOLD PE History Chart
PeriodPriceAdj. EPSTTMPE
Q3 2024
11/6/2024
11.240.100.1574.9
Q2 2024
8/8/2024
11.320.06-0.02NA
Q1 2024
5/9/2024
9.48-0.02-0.23NA
Q4 2023
2/28/2024
12.950.01-0.39NA
Q3 2023
11/8/2023
11.36-0.07-0.59NA
Q2 2023
8/8/2023
13.86-0.15-0.64NA
Q1 2023
5/10/2023
11.58-0.18-0.70NA
Q4 2022
3/1/2023
13.54-0.19-0.82NA
Q3 2022
11/7/2022
10.31-0.12-0.92NA
Q2 2022
8/4/2022
10.94-0.21-0.99NA
Q1 2022
5/9/2022
6.23-0.30-0.97NA
Q4 2021
2/24/2022
8.48-0.29-0.92NA
Q3 2021
11/9/2021
11.32-0.19-0.90NA
Q2 2021
8/5/2021
10.06-0.19-0.93NA
Q1 2021
5/10/2021
9.39-0.25-0.94NA
Q4 2020
3/1/2021
11.79-0.27-1.04NA
Q3 2020
11/5/2020
21.34-0.22-1.12NA
Q2 2020
8/10/2020
15.23-0.20-1.14NA
Q1 2020
5/7/2020
11.62-0.35-1.30NA
Q4 2019
3/2/2020
9.32-0.35-1.34NA
Q3 2019
11/11/2019
9.28-0.24-1.40NA
Q2 2019
8/8/2019
11.39-0.36-1.47NA
Q1 2019
5/8/2019
13.11-0.39-1.44NA
Q4 2018
2/28/2019
12.10-0.41-1.33NA
Q3 2018
11/5/2018
11.71-0.31-1.33NA
Q2 2018
8/7/2018
15.63-0.33-1.43NA
Q1 2018
5/8/2018
13.58-0.28-1.44NA
Q4 2017
2/28/2018
13.76-0.41-1.55NA
Q3 2017
11/8/2017
13.17-0.41-1.56NA
Q2 2017
8/7/2017
13.90-0.34-1.48NA
Q1 2017
5/9/2017
6.65-0.39-1.54NA
Q4 2016
3/1/2017
7.60-0.42-1.50NA
Q3 2016
11/7/2016
7.43-0.33-1.43NA
Q2 2016
8/9/2016
6.34-0.40-1.42NA
Q1 2016
5/3/2016
7.07-0.35-1.29NA
Q4 2015
2/26/2016
6.23-0.35-1.19NA
Q3 2015
11/3/2015
8.83-0.32-1.08NA
Q2 2015
8/5/2015
18.19-0.27-0.98NA
Q1 2015
5/5/2015
10.28-0.25-0.93NA
Q4 2014
3/3/2015
8.48-0.24-0.93NA
Q3 2014
11/6/2014
5.88-0.22-0.91NA
Q2 2014
8/7/2014
4.02-0.22-0.98NA
Q1 2014
5/5/2014
2.15-0.25-1.07NA
Q4 2013
3/3/2014
2.57-0.22-1.17NA
Q3 2013
11/12/2013
2.04-0.29-1.15NA
Q2 2013
8/7/2013
2.62-0.31NANA
Q1 2013
5/9/2013
3.11-0.35NANA
Q4 2012
3/12/2013
3.10-0.20NANA
Quotes delayed 20 minutes

Email EnvelopeFree FOLD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Amicus Therapeutics (FOLD) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

FONR PE Ratio History
FREQ PE Ratio History
FSTX PE Ratio History
FTRE PE Ratio History
FULC PE Ratio History
FVE PE Ratio History
FWBI PE Ratio History
GALT PE Ratio History
GBIO PE Ratio History
GBT PE Ratio History
How should the FOLD historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Amicus Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this FOLD Historical PE Ratio page.

What is the average historical PE for FOLD based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The FOLD historical PE ratio using the annualized quarterly earnings method works out to 133.0.

What is the average historical PE for FOLD based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The FOLD historical PE ratio using the TTM earnings method works out to 74.9.

What is the average historical PE for FOLD based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The FOLD historical PE ratio using the annualized median TTM earnings method works out to 0.12.

On this page we presented the FOLD Historical PE Ratio information for Amicus Therapeutics' stock. The average FOLD historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 133.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average FOLD historical PE based on this TTM earnings result method is 74.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this FOLD historical PE result, against the recent PE: when this page was posted on 11/7/2024, the most recent closing price for FOLD had been 10.98, and the most recent quarterly earnings result, annualized, was 0.4. Meanwhile, the most recent TTM earnings summed to 0.15. From these numbers, we calculate the recent FOLD PE on 11/7/2024 based on annualized quarterly EPS was 27.4. Based on FOLD's history, that recent PE is low relative to the historical average, with the recent PE 79.4% lower than the historical average PE across our data set for Amicus Therapeutics. Looking at the recent FOLD PE on 11/7/2024 based on TTM EPS, we calculate the ratio at 73.2. Based on FOLD's history, that recent PE is low relative to the historical average, with the recent PE 2.3% lower than the average PE across our Amicus Therapeutics data set with TTM EPS used in the calculation at each period.

Another interesting FOLD historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for FOLD, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for FOLD, we start with the past four EPS numbers and we first sort them from lowest to highest: -0.02, 0.01, 0.06, and 0.10. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.01 and 0.06 — which gives us the median of 0.03. Basically the way to think about this 0.03 number is this: for the trailing four earnings reports, 0.03 marks the "middle ground" number where FOLD has reported a value higher than 0.03 half the time, and has reported a value lower than 0.03 half the time. Annualizing that median value then gets us to 0.12/share, which we use as the denominator in our next PE calculation. With 10.98 as the numerator (as of 11/7/2024), the calculation is then 10.98 / 0.12 = 91.5 as the FOLD PE ratio as of 11/7/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on FOLD or any other given stock, valuation analysis for FOLD can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Amicus Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for FOLD. Thanks for visiting, and the next time you need to research FOLD Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding ESLA, DAL market cap history, SPLK shares outstanding history.

 

FOLD Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.